Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.85 HKD | -0.61% | -4.90% | -26.96% |
May. 02 | Alphamab Oncology's 2023 Loss Narrows as Revenue Rises | MT |
Apr. 10 | Alphamab Oncology Presents Phase-I Clinical Trial Results at 2024 AACR Annual Meeting | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
603M | - | |||||
55.07B | - | |||||
40.22B | ||||||
41.79B | ||||||
28.17B | ||||||
26.28B |
- Stock Market
- Equities
- 9966 Stock
- Charts Alphamab Oncology
- Sector Chart